Although much remains to be understood about the integrative molecular mechanisms involved in both the regulation and mode of action, PGC-1α modulation may be an interesting therapeutic target that may have significant benefits for a number of metabolic diseases. The gene discussed is PPARGC1A; the disease is metabolic disease.